Targeted BRCA Gene Analysis with Oxford Nanopore![Matt Parker]()
Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose…
June 19, 2023
4 min
#workflows 57
EPI2ME 23.06-01 Release![Stephen Rudd]()
Dear Nanopore Community, With this first June release, we are delighted to update our EPI2ME…
June 14, 2023
1 min
EPI2ME 23.05-02 Release![Stephen Rudd]()
Dear Nanopore Community, With this post London Calling '23 bioinformatics product release, we are…
May 31, 2023
1 min
Selecting the correct databases in the wf-metagenomics
Our metagenomics workflow, wf-metagenomics , gives users the ability to unveil the taxonomic…
May 11, 2023
3 min
EPI2ME Labs 23.05-01 Release![Stephen Rudd]()
Dear Nanopore Community, With our first release of May, we are delighted to introduce two new…
May 03, 2023
2 min
SARS-CoV-2 Midnight Chemistry V14 Update![Matt Parker]()
Introduction Please note
the wf-artic workflow has now been updated to select the Medaka variant…
April 19, 2023
2 min
Information
© 2020 - 2024 Oxford Nanopore Technologies plc. All rights reserved. Registered Office: Gosling Building, Edmund Halley Road, Oxford Science Park, OX4 4DQ, UK | Registered No. 05386273 | VAT No 336942382. Oxford Nanopore Technologies, the Wheel icon, EPI2ME, Flongle, GridION, Metrichor, MinION, MinIT, MinKNOW, Plongle, PromethION, SmidgION, Ubik and VolTRAX are registered trademarks of Oxford Nanopore Technologies plc in various countries. Oxford Nanopore Technologies products are not intended for use for health assessment or to diagnose, treat, mitigate, cure, or prevent any disease or condition.